- Report
- November 2021
Asia Pacific
From €13336EUR$14,500USD£11,280GBP
- Report
- July 2024
- 280 Pages
Global
From €1709EUR$1,859USD£1,446GBP
€2442EUR$2,655USD£2,065GBP
- Report
- October 2023
- 391 Pages
Global
From €2298EUR$2,499USD£1,944GBP
€3283EUR$3,570USD£2,777GBP
The Immunodiagnostic market is a segment of the In Vitro Diagnostics (IVD) industry. It is focused on the development and production of tests that use antibodies to detect the presence of a specific antigen in a sample. These tests are used to diagnose a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases. Immunodiagnostics are also used to monitor the effectiveness of treatments and to assess the risk of developing certain diseases.
Immunodiagnostics are typically performed in a laboratory setting, using a variety of techniques such as enzyme-linked immunosorbent assays (ELISA), immunofluorescence, and immunohistochemistry. These tests are often used in combination with other diagnostic methods, such as imaging and molecular diagnostics, to provide a more comprehensive diagnosis.
Some of the major companies in the Immunodiagnostic market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more